CareDx (NASDAQ: CDNA) Names Longtime Patient Advocate Art Torres to Board of Directors
Art Torres Adds Expertise in Regenerative Medicine and Organ Procurement to the CareDx Board CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of patient advocate, political leader, and former state senator Art […]